Journal
ELIFE
Volume 6, Issue -, Pages -Publisher
ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.22693
Keywords
-
Categories
Funding
- Wellcome [102770/Z/13/Z]
- Medical Research Council [MR/K50127X/1]
- Medical Research Council [1509242] Funding Source: researchfish
- Wellcome Trust [102770/Z/13/Z] Funding Source: researchfish
- Wellcome Trust [102770/Z/13/Z] Funding Source: Wellcome Trust
Ask authors/readers for more resources
Hypoxia Inducible transcription Factors (HIFs) are principally regulated by the 2-oxoglutarate and Iron(II) prolyl hydroxylase (PHD) enzymes, which hydroxylate the HIF alpha subunit, facilitating its proteasome-mediated degradation. Observations that HIF alpha hydroxylation can be impaired even when oxygen is sufficient emphasise the importance of understanding the complex nature of PHD regulation. Here, we use an unbiased genome-wide genetic screen in near-haploid human cells to uncover cellular processes that regulate HIF1 alpha. We identify that genetic disruption of the Vacuolar H+ ATPase (V-ATPase), the key proton pump for endo-lysosomal acidification, and two previously uncharacterised V-ATPase assembly factors, TMEM199 and CCDC115, stabilise HIF1 alpha in aerobic conditions. Rather than preventing the lysosomal degradation of HIF1 alpha, disrupting the V-ATPase results in intracellular iron depletion, thereby impairing PHD activity and leading to HIF activation. Iron supplementation directly restores PHD catalytic activity following V-ATPase inhibition, revealing important links between the V-ATPase, iron metabolism and HIFs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available